TI
MREO

Tidal Investments’s Mereo BioPharma MREO Stock Holding History

Tidal Investments’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-319,390
Closed -$738K – 1710
2023
Q4 		$738K Sell
319,390
-12,524
-4% -$24K 0.02% 774
2023
Q3 		$428K Hold
331,914
– – 0.01% 908
2023
Q2 		$438K Hold
331,914
– – 0.01% 885
2023
Q1 		$235K Buy
331,914
+18,786
+6% +$16.9K 0.01% 1117
2022
Q4 		$235K Buy
313,128
+31,310
+11% +$25.7K 0.01% 980
2022
Q3 		$243K Buy
281,818
+6,262
+2% +$7.66K 0.01% 871
2022
Q2 		$309K Buy
+275,556
New +$214K 0.01% 760

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Tidal Investments's MREO Position: Q1 2024 in Review

Tidal Investments sold out of Mereo BioPharma (MREO) in Q1 2024, closing a stake of 319,390 shares — an estimated $738K sold.

Tidal Investments first reported a position in MREO in Q2 2022 and held it in 7 quarters. The position peaked at $738K in Q4 2023. 80 funds tracked by Wall St. Rank hold MREO as of Q1 2024.

  • Tidal Investments reported no remaining Mereo BioPharma position as of Q1 2024 after selling out during the quarter.
  • Tidal Investments sold 319,390 Mereo BioPharma shares in Q1 2024, an estimated $738K.
  • Tidal Investments first reported a position in Mereo BioPharma in Q2 2022 and held it in 7 quarters.
  • Tidal Investments's Mereo BioPharma position peaked at $738K in Q4 2023.
  • 80 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2024.

Based on Tidal Investments's 13F filing for Q1 2024, filed 16 May 2024.